×
Back to Agenda
S3-1 - What’s new in ICH guidelines? (1)
Session Chair(s)
Yoshiaki Uyama, PHD, MS, RPH
Associate Executive Director, Regulatory Science Center
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Janis Bernat, MSC
Director, Scientific and Regulatory Affairs
IFPMA, Switzerland
Speaker(s)
Nihan Burul Bozkurt, PHD
Association of Research Based Pharmaceutical Companies (AIFD), Türkiye, Turkey
Health Policies Director
Osamu Komiyama
Pfizer R&D Japan G.K., Japan
Senior Manager, Statistical Research & Data Science
Xiaoni Liu, PHD
Novartis China, Hematology Biostatistics Team, China
Executive Director, Head of Analytics China,GDD China Data & Digital
Have an account?